How have the shares performed?
Zomedica Corp. (ZOM) saw an uptrend of 3.46% in the recent trading with $0.75 being its most recent. The current price level -74.40% lower than the highest price of $2.91 marked by the stock while trading over the past 52-weeks, whereas it is 1086.47% higher than the lowest price of $0.06 the company dropped to over past 52-weeks. The latest news story on ZOM appeared in GlobeNewswire under the title “Zomedica Announces First Quarter 2021 Financial Results” on May-12-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -42.68% below one month high and is +7.99% above of the lowest during that time. Looking into the simple moving average, Zomedica Corp. (ZOM)’s stock stands at a SMA-50 of $1.3604 while that of 5-day is reading $0.7726.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and ZOM’s SMA-200 as of now is $0.7213.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.00 for the stock.
Zomedica Corp. Earnings – What Happened With ZOM
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
ZOM – Zomedica Corp. Stock Earnings Estimates
The perspective of Zomedica Corp. (AMEX:ZOM)’s current quarter earnings identifies that analysts are in consensus over the estimate of 0 for stock’s EPS in the current quarter. Company’s EPS for the last quarter was -0.01.
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 941.88 million. ZOM does have institutional investors; and they hold 8.80% of the stock.
Zomedica Corp. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 13 new insider purchases involving 2,257,776 shares. On the other hand, ZOM declared 1,639,176 shares have been sold in 13 insider transactions over the past three months.
As on Dec 30, 2020, Vanguard Group, Inc. (The) was the top most holder in Zomedica Corp. (AMEX:ZOM) with an ownership of 19.34 million shares of the company or 17.90% of the stake worth $4.46 million. The filing also reveals Blackrock Inc. as the second largest holder in the company with a control over 15.89% of the outstanding shares. Its stake is worth $27.13 million for having 17.17 million shares in hand.
Cambridge Investment Research Advisors Inc. also came holding a key position in the company during the recent quarter and it now holds 11.34% of the outstanding shares. With this there are now 89 institutions which have possession in ZOM’s shares.
Currently, the stock has been recommended as Moderate Buy by 1 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.00 for the stock.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Zomedica Corp. was 30.99 while posting a debt to equity ratio of 0.01. The count was 2.13 for long-term debt to equity ratio.